Scarica l'app Stockscreener
8.56
1.27%
-0.11
Dopo l'orario di chiusura:
8.66
0.10
+1.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.67
Aprire:
$8.63
Volume 24 ore:
3.09M
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.41B
Reddito:
$596.34M
Utile/perdita netta:
$-87.84M
Rapporto P/E:
-14.33
EPS:
-0.5975
Flusso di cassa netto:
$-97.62M
1 W Prestazione:
-16.08%
1M Prestazione:
-15.33%
6M Prestazione:
+27.00%
1 anno Prestazione:
+18.89%
Intervallo 1D:
$8.47
$8.84
Intervallo di 1 settimana:
$8.35
$10.59
Portata 52W:
$6.13
$11.97
Novavax Inc Stock (NVAX) Company Profile
Nome
Novavax Inc
Settore
Industria
Telefono
240-268-2000
Indirizzo
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
8.56 | 1.43B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
435.71 | 113.14B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
601.65 | 64.60B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
862.18 | 54.97B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.22 | 39.75B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
144.19 | 31.79B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Ripresa | H.C. Wainwright | Buy |
| 2025-08-20 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Iniziato | Citigroup | Sell |
| 2025-02-28 | Iniziato | BTIG Research | Buy |
| 2024-07-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Reiterato | B. Riley Securities | Buy |
| 2022-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-02 | Iniziato | Jefferies | Hold |
| 2022-09-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2022-02-22 | Ripresa | Jefferies | Buy |
| 2022-01-21 | Iniziato | Cowen | Outperform |
| 2021-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Iniziato | Jefferies | Buy |
| 2020-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Reiterato | B. Riley FBR | Buy |
| 2020-06-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Reiterato | B. Riley FBR | Buy |
| 2020-05-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-08-14 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-12-11 | Iniziato | Oppenheimer | Outperform |
| 2018-11-26 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
Mostra tutto
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Shares Decline Amid Transition to Royalty Model - GuruFocus
Novavax rises after six sessions of decline - MSN
Novavax set for a seventh straight decline - MSN
(NVAX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax (NVAX) up 10.4% since last earnings report: Can it continue? - MSN
Novavax, Inc. (NVAX) is attracting investor attention: Here is what you should know - MSN
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore
NVAX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Novavax Q1 2026 slides: partnership revenue surges amid strategic shift - Investing.com
Earnings call transcript: Novavax Q1 2026 beats forecasts, stock surges - Investing.com
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax Inc stock (US6707721049): Q1 2026 results and valuation metrics in focus - AD HOC NEWS
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax, Inc. Trade Ideas — BSESOF:NVV1 - TradingView
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax beats first-quarter revenue estimates on strength in vaccine deals - marketscreener.com
Novo Nordisk opens Czech facility for obesity drugs - marketscreener.com
Novavax rises after strong Q1 beat driven by Pfizer deal - MSN
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. (NVAX) Investors of Filing Deadline in Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Novavax to Participate in 2026 Jefferies Global Healthcare Confe - GuruFocus
Novavax to Participate in 2026 Jefferies Global Healthcare Conference - PR Newswire
Novavax Inc stock (US6707721049): Analyst consensus points to hold as NVAX trades near 11 USD - AD HOC NEWS
Novavax fireside chat at 2026 Jefferies Global Healthcare Conference - Stock Titan
Novavax Stock Soars 13.57%, Hits Intraday High of $10.52 - Markets Mojo
Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Liquidity Mapping Around (NVAX) Price Events - Stock Traders Daily
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc stock (US6707721049): shares trade around USD 10 after recent volatility and licensing f - AD HOC NEWS
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA advisers recommend COVID vaccines be updated to target current dominant variant - Reuters
Novavax Inc stock (US66987V1098): NVAX trades at $11.09 on Nasdaq - AD HOC NEWS
R. Draghia Akli sells 30,000 NVAX shares (NASDAQ: NVAX) - Stock Titan
Why Novavax (NVAX) Stock Is Trading Up Today - Yahoo Finance
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant - Reuters
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
3 Reasons NVAX is Risky and 1 Stock to Buy Instead - Yahoo Finance
Operating margin % of Novavax, Inc. – BSESOF:NVV1 - TradingView
Small-Cap Stocks to Avoid: Peloton, Novavax, and BKV Face Financial RisksNews and Statistics - IndexBox
Why (NVAX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Assessing Novavax (NVAX) Valuation As Trading Swings Revive Investor Interest - Yahoo Finance
Novavax Inc Azioni (NVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.20%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):